<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS191787</article-id><article-id pub-id-type="doi">10.1101/2023.11.26.568719</article-id><article-id pub-id-type="archive">PPR764865</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">2</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>CK-666 and CK-869 differentially inhibit Arp2/3 iso-complexes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cao</surname><given-names>LuYan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Shaina</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Basant</surname><given-names>Angika</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mladenov</surname><given-names>Miroslav</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Way</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib></contrib-group><aff id="A1"><label>1</label>The Francis Crick Institute, London, UK</aff><aff id="A2"><label>2</label>Department of Infectious Disease, Imperial College, London, UK</aff><author-notes><corresp id="CR1">
<label>#</label>To whom correspondence should be addressed: <email>luyan.cao@crick.ac.uk</email> and <email>michael.way@crick.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>27</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>26</day><month>11</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The inhibitors, CK-666 and CK-869, are widely used to probe the function of actin nucleation by the Arp2/3 complex <italic>in vitro</italic> and in cells. However, in mammals, the Arp2/3 complex consists of 8 iso-complexes, as three of its subunits (Arp3, ArpC1, ArpC5) are encoded by two different genes. Here, we used recombinant Arp2/3 with defined composition to assess the activity of CK-666 and CK-869 against iso-complexes. We demonstrate that both inhibitors prevent linear actin filament formation when ArpC1A- or ArpC1B-containing complexes are activated by SPIN90. In contrast, inhibition of actin branching depends on iso-complex composition. Both drugs prevent actin branch formation by complexes containing ArpC1A, but only CK-869 can inhibit ArpC1B-containing complexes. Consistent with this, in bone marrow-derived macrophages which express low levels of ArpC1A, CK-869 but not CK-666, impacted phagocytosis and cell migration. CK-869 is also only able to inhibit Arp3- but not Arp3B-containing iso-complexes. Our findings have important implications for the interpretation of results using CK-666 and CK-869, given that the relative expression levels of ArpC1 and Arp3 isoforms in cells and tissues remains largely unknown.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">The Arp2/3 complex is an important evolutionarily conserved nucleator of actin filaments (<xref ref-type="bibr" rid="R39">Machesky <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="R48">Papalazarou &amp; Machesky, 2021</xref>; <xref ref-type="bibr" rid="R72">Welch <italic>et al</italic>, 1997</xref>). The complex regulates the architecture and dynamics of actin cytoskeleton by initiating the formation of both branched and linear actin filaments (<xref ref-type="bibr" rid="R9">Cao &amp; Way, 2024</xref>; <xref ref-type="bibr" rid="R18">Espinoza-Sanchez <italic>et al</italic>, 2018</xref>; <xref ref-type="bibr" rid="R24">Gautreau <italic>et al</italic>, 2022</xref>; <xref ref-type="bibr" rid="R43">Mullins <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="R70">Wagner <italic>et al</italic>, 2013</xref>). When activated by class I nucleating promoting factors (NPFs), such as WAVE, N-WASP and WASH, the Arp2/3 complex binds to the side of a pre-existing (mother) actin filament and nucleates the formation of a new (daughter) actin branch (<xref ref-type="bibr" rid="R18">Espinoza-Sanchez <italic>et al</italic>., 2018</xref>; <xref ref-type="bibr" rid="R41">Molinie &amp; Gautreau, 2018</xref>; <xref ref-type="bibr" rid="R65">Smith <italic>et al</italic>, 2013</xref>). Alternatively, Arp2/3 activation by SPIN90 (also known as WISH, NCKIPSD, Dip1) inhibits the association of the complex with an existing actin filament and generates a new linear actin filament (<xref ref-type="bibr" rid="R38">Luan <italic>et al</italic>, 2018</xref>; <xref ref-type="bibr" rid="R70">Wagner <italic>et al</italic>., 2013</xref>). Through these two activities, the Arp2/3 complex plays essential roles in various cell processes, including endocytosis, cell migration, regulation of the actin cortex and DNA repair (<xref ref-type="bibr" rid="R10">Cao <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R27">Hinze &amp; Boucrot, 2018</xref>; <xref ref-type="bibr" rid="R48">Papalazarou &amp; Machesky, 2021</xref>; <xref ref-type="bibr" rid="R62">Schrank <italic>et al</italic>, 2018</xref>; <xref ref-type="bibr" rid="R73">Wu <italic>et al</italic>, 2012</xref>).</p><p id="P3">The Arp2/3 complex consists of seven subunits, including two <underline>A</underline>ctin <underline>R</underline>elated <underline>P</underline>roteins: Arp2, Arp3 and ArpC1-ArpC5. Upon activation by class I NPFs, the ArpC1-5 subunits interact with the mother actin filament while Arp2 and Arp3 act as a template to nucleate a new daughter filament (<xref ref-type="bibr" rid="R12">Chou <italic>et al</italic>, 2022</xref>; <xref ref-type="bibr" rid="R16">Ding <italic>et al</italic>, 2022</xref>; <xref ref-type="bibr" rid="R19">Fassler <italic>et al</italic>, 2020</xref>). In mammals but not lower eukaryotes, such as yeast and amoeba, Arp3, ArpC1 and ArpC5 exist as two different isoforms that are encoded by separate genes (<xref ref-type="bibr" rid="R3">Balasubramanian <italic>et al</italic>, 1996</xref>; <xref ref-type="bibr" rid="R30">Jay <italic>et al</italic>, 2000</xref>; <xref ref-type="bibr" rid="R40">Millard <italic>et al</italic>, 2003</xref>). In humans, Arp3 and Arp3B, ArpC1A and ArpC1B, ArpC5 and ArpC5L are 91, 67 and 67% identical respectively (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>, 2016</xref>). Hence, in mammals, the Arp2/3 complex is not a single species but a group of eight different iso-complexes. Moreover, these iso-complexes have different molecular properties as Arp2/3 complexes containing ArpC1B and ArpC5L are significantly better at stimulating actin assembly than those with ArpC1A and ArpC5 (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>., 2016</xref>), while actin networks assembled by Arp3B complexes disassemble faster than those formed by Arp3 complexes (<xref ref-type="bibr" rid="R23">Galloni <italic>et al</italic>, 2021</xref>). Structural analysis reveals that the higher branching efficiency of ArpC5L complexes is mediated by its disordered N-terminus (<xref ref-type="bibr" rid="R69">von Loeffelholz <italic>et al</italic>, 2020</xref>). Not surprisingly given their different properties, Arp2/3 iso-complexes have different cellular functions (<xref ref-type="bibr" rid="R20">Fassler <italic>et al</italic>, 2023</xref>; <xref ref-type="bibr" rid="R42">Molinie <italic>et al</italic>, 2019</xref>; <xref ref-type="bibr" rid="R53">Roman <italic>et al</italic>, 2017</xref>; <xref ref-type="bibr" rid="R58">Sadhu <italic>et al</italic>, 2023</xref>). The importance of Arp2/3 iso-complexes in cell and tissue homeostasis is also underscored by the observation that loss of function mutations in human ArpC1B lead to severe inflammation and immunodeficiency (<xref ref-type="bibr" rid="R7">Brigida <italic>et al</italic>, 2018</xref>; <xref ref-type="bibr" rid="R31">Kahr <italic>et al</italic>, 2017</xref>; <xref ref-type="bibr" rid="R34">Kuijpers <italic>et al</italic>, 2017</xref>; <xref ref-type="bibr" rid="R49">Randzavola <italic>et al</italic>, 2019</xref>; <xref ref-type="bibr" rid="R66">Somech <italic>et al</italic>, 2017</xref>; <xref ref-type="bibr" rid="R68">Volpi <italic>et al</italic>, 2019</xref>). It has also recently been reported that loss of ArpC5 expression results in multiple congenital anomalies, recurrent infections, systemic inflammation, and mortality (<xref ref-type="bibr" rid="R47">Nunes-Santos <italic>et al</italic>, 2023</xref>; <xref ref-type="bibr" rid="R64">Sindram <italic>et al</italic>, 2023</xref>).</p><p id="P4">CK-666 and CK-869 are widely used as chemical inhibitors to probe the function of Arp2/3 complex in biochemical assays, cells and tissues (<xref ref-type="bibr" rid="R46">Nolen <italic>et al</italic>, 2009</xref>; <xref ref-type="bibr" rid="R56">Rotty <italic>et al</italic>, 2013</xref>; <xref ref-type="bibr" rid="R76">Yang <italic>et al</italic>, 2012</xref>). CK-666 binds between Arp2 and Arp3 to block the movement of these two subunits, which is required for activation of the Arp2/3 complex (<xref ref-type="bibr" rid="R2">Baggett <italic>et al</italic>, 2012</xref>; <xref ref-type="bibr" rid="R26">Hetrick <italic>et al</italic>, 2013</xref>; <xref ref-type="bibr" rid="R57">Rouiller <italic>et al</italic>, 2008</xref>). CK-869 inhibits this activating conformational change by binding to a hydrophobic pocket in Arp3 (<xref ref-type="bibr" rid="R26">Hetrick <italic>et al</italic>., 2013</xref>). CK-869 has also been reported to inhibit microtubule assembly <italic>in vitro</italic> and cells (<xref ref-type="bibr" rid="R75">Yamagishi <italic>et al</italic>, 2018</xref>). Taking their different properties into consideration, we wondered whether all Arp2/3 iso-complexes can be inhibited by CK-666 and CK-869. In addition, it also remains to be established whether both drugs are equally effective against class 1 NPF- and SPIN90- mediated activation of Arp2/3 iso-complexes. To address these questions, we performed <italic>in vitro</italic> pyrene and TIRF assays, to examine the impact of CK-666 and CK-869 on the ability of defined recombinant Arp2/3 iso-complexes to nucleate actin when activated by the VCA domain of N-WASP or SPIN90. We found that the ability of CK-666 and CK-869 to inhibit Arp2/3 iso-complexes depends on their subunit composition and activation mechanism. Our observations have important implications for the interpretation of results from experiments using CK666 and CK869 to inhibit mammalian Arp2/3 complex both in cells and using purified complexes with unknown isoform composition. They also provide insights into the differences of Arp2/3 iso-complex activation by VCA domains and SPIN90.</p></sec><sec id="S2" sec-type="results | discussion"><title>Results and discussion</title><sec id="S3"><title>CK-869, but not CK-666, fully inhibits Vaccinia-induced actin polymerisation</title><p id="P5">During their egress from infected cells, newly assembled vaccinia virus virions that have fused with the plasma membrane and remain attached to the cell induce actin polymerization to enhance their spread into neighbouring uninfected cells (<xref ref-type="bibr" rid="R14">Cudmore <italic>et al</italic>, 1995</xref>; <xref ref-type="bibr" rid="R15">Cudmore <italic>et al</italic>, 1996</xref>; <xref ref-type="bibr" rid="R22">Frischknecht <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="R36">Leite &amp; Way, 2015</xref>). These virions stimulate actin assembly by locally activating Src and Abl family kinases, which results in the recruitment of a signalling network involving the class I NPF, N-WASP that activates Arp2/3 complex dependent actin polymerization (<xref ref-type="bibr" rid="R17">Donnelly <italic>et al</italic>, 2013</xref>; <xref ref-type="bibr" rid="R22">Frischknecht <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="R29">Humphries <italic>et al</italic>, 2014</xref>; <xref ref-type="bibr" rid="R44">Newsome <italic>et al</italic>, 2004</xref>; <xref ref-type="bibr" rid="R45">Newsome <italic>et al</italic>, 2006</xref>; <xref ref-type="bibr" rid="R50">Reeves <italic>et al</italic>, 2005</xref>; <xref ref-type="bibr" rid="R59">Scaplehorn <italic>et al</italic>, 2002</xref>). The resulting actin polymerisation beneath the virion appears as an actin tail when labelled with phalloidin or the branched actin marker cortactin (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Vaccinia induced actin tails have been used as a model system to study actin assembly in the cells (<xref ref-type="bibr" rid="R5">Basant &amp; Way, 2022</xref>, <xref ref-type="bibr" rid="R6">2023</xref>; <xref ref-type="bibr" rid="R71">Weisswange <italic>et al</italic>, 2009</xref>). We also previously took advantage of vaccinia to demonstrate that Arp2/3 iso-complexes have different cellular activities (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="R23">Galloni <italic>et al</italic>., 2021</xref>). We decided to use the same model to examine whether CK-666 and CK-869 differentially impact the ability of the vaccinia to promote branched actin network assembly. Examination of the literature reveals that these drugs are typically used at 100 μM in cell-based assays. Given this, we treated vaccinia infected HeLa cells 8 hours post infection with 50, 100, 200 and 300 μM CK-666 or CK-869 for 60 minutes and quantified the ability of the virus to stimulate branched actin assembly using cortactin as a marker (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). We found that while increasing doses of CK-869 result in a near-complete loss of virus induced actin assembly, CK-666 decreased (~30%) but did not abolish actin polymerisation even at 300 μM (<xref ref-type="fig" rid="F1">Figure 1B, C</xref>). The actin tails induced by the virus in the presence of CK-666, however, were shorter than in the DMSO control (<xref ref-type="fig" rid="F1">Figure 1A, B</xref>). The ability of vaccinia to stimulate actin polymerization depends on their microtubule transport to the cell periphery and fusion with the plasma membrane (<xref ref-type="bibr" rid="R28">Hollinshead <italic>et al</italic>, 2001</xref>; <xref ref-type="bibr" rid="R36">Leite &amp; Way, 2015</xref>; <xref ref-type="bibr" rid="R44">Newsome <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="R51">Rietdorf <italic>et al</italic>, 2001</xref>). The inhibitory effect of CK-869 on actin assembly, however, was not the consequence of the lack of the virus reaching the plasma membrane as extracellular virions were readily detected on the outside of the cell (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Our observations on vaccinia infected HeLa cells demonstrate that CK-666 and CK-869 do not have the same impact on Arp2/3 driven actin assembly.</p></sec><sec id="S4"><title>CK-666 does not inhibit ArpC1B-containing Arp2/3 complexes</title><p id="P6">It is not straightforward to deconvolve results from vaccinia infected cells as the precise levels of the 8 different Arp2/3 iso-complexes, which may not be equally inhibited by CK-666 or CK-869 are not known in HeLa cells. We therefore examined the impact of the two inhibitors on defined recombinant Arp2/3 complexes activated by GST-N-WASP-VCA using <italic>in vitro</italic> pyrene actin polymerisation assays (<xref ref-type="fig" rid="F2">Figure 2</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 2 and 3</xref>). We initially used Arp2/3 iso-complexes containing Arp3 given it is much more abundant than Arp3B in cells and tissues (<xref ref-type="bibr" rid="R23">Galloni <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="R25">Hein <italic>et al</italic>, 2015</xref>; <xref ref-type="bibr" rid="R35">Kulak <italic>et al</italic>, 2014</xref>). We found both inhibitors suppress activation of ArpC1A containing Arp2/3 complexes but only CK-869 and not CK-666 can inhibit those with ArpC1B (<xref ref-type="fig" rid="F2">Figure 2A</xref>). A similar difference in inhibition was seen in complexes with ArpC5 or ArpC5L (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>). The lack of inhibition of ArpC1B complexes by CK-666 was unexpected given that the drug binds between Arp2 and Arp3 to block their movement during Arp2/3 complex activation (<xref ref-type="bibr" rid="R2">Baggett <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="R26">Hetrick <italic>et al</italic>., 2013</xref>).</p><p id="P7"><italic>In vitro</italic> pyrene actin polymerisation assays are an indirect measurement of bulk actin assembly so provide no information at the level of individual filaments. To directly quantify actin branch initiation efficiency, we therefore performed TIRF assays where the generation of new branches is observed over time by incubating fluorescent actin filaments with G-actin labelled with a different fluorophore (<xref ref-type="bibr" rid="R52">Risca <italic>et al</italic>, 2012</xref>). We found that 100 μM CK-869 dramatically reduces the branching rate of ArpC1A/C5, ArpC1A/C5L, ArpC1B/C5 and ArpC1B/C5L containing complexes (<xref ref-type="fig" rid="F2">Figure 2B</xref>). In contrast, 100 μM CK-666 was only able to inhibit ArpC1A containing Arp2/3 complexes.</p><p id="P8">Previous <italic>in vitro</italic> analysis determined that the half-maximal inhibitory concentration value (IC<sub>50</sub>) of CK-666 for human and bovine Arp2/3 purified from platelets and thymus was 4 and 17 μM respectively, while it was 11 μM for CK-869 on bovine Arp2/3 (<xref ref-type="bibr" rid="R46">Nolen <italic>et al</italic>., 2009</xref>). As these Arp2/3 complexes are purified from natural sources they are likely to contain different iso-complexes. Given this and our in vitro observations, we determined the IC<sub>50</sub> for CK-666 and CK-869 on defined Arp2/3 iso-complexes activated by VCA (<xref ref-type="fig" rid="F2">Figure 2C</xref>). We were unable to determine an IC<sub>50</sub> for ArpC1B/C5L but obtained a value of 19.9 μM for CK-666 with ArpC1A/C5L containing complexes. The lower IC<sub>50</sub> values we obtained for CK-869 clearly demonstrate that the drug is a significantly better inhibitor than CK-666. Moreover, in an ArpC5L background, CK-869 is more effective against complexes containing ArpC1A (IC<sub>50</sub> 0.86 μM) than those with ArpC1B (IC<sub>50</sub> 3.55 μM) (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Although the ArpC5/ArpC5L isoforms are not differentially impacted by either CK-666 or CK-869 (<xref ref-type="fig" rid="F2">Figure 2B</xref>), the latter appears slightly more effective against ArpC5 containing complexes (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3B</xref>). Our results clearly demonstrate that CK-666 inhibits ArpC1A but not ArpC1B containing Arp2/3 complexes from generating actin branches, whereas CK-869 inhibits both ArpC1 iso-complexes. The results from our <italic>in vitro</italic> assays offer an explanation why CK-666 does not fully suppress vaccinia induced actin polymerization in HeLa cells, which express ~ 2.3 times as much ArpC1B as ArpC1A (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>., 2016</xref>).</p></sec><sec id="S5"><title>CK-666 has no impact on macrophage phagocytosis and motility</title><p id="P9">Single-cell transcriptomics, tissue specific mRNA expression and proteomic analysis indicate that ArpC1B is highly expressed in immune cells compared to ArpC1A (<xref ref-type="bibr" rid="R31">Kahr <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="R32">Karlsson <italic>et al</italic>, 2021</xref>; <xref ref-type="bibr" rid="R33">Kim <italic>et al</italic>, 2014</xref>; <xref ref-type="bibr" rid="R74">Wu <italic>et al</italic>, 2009</xref>). Given this, we predicted that in contrast to CK-869, CK-666 will have little or no effect on Arp2/3 complex dependent activities in immune cells. After incubating murine bone marrow-derived macrophages with 100 μM of Arp2/3 inhibitor, we observed that the morphology of macrophages treated with CK-869 changed significantly, with cells rounding up to become less spread (<xref ref-type="fig" rid="F3">Figure 3A, B</xref>, <xref ref-type="supplementary-material" rid="SD2">Movie 1</xref>). In contrast, CK-666 treated macrophages were indistinguishable from DMSO treated controls. In addition, treatment with CK-666 had no impact on macrophage motility (<xref ref-type="fig" rid="F3">Figure 3C</xref>, <xref ref-type="supplementary-material" rid="SD2">Movie 1</xref>). CK-869, on the other hand, unexpectedly increases macrophage movement. However, a similar increase in motility has been observed in macrophages that contain no functional</p><p id="P10">Arp2/3 complex because they lack ArpC2 (<xref ref-type="bibr" rid="R55">Rotty <italic>et al</italic>, 2017</xref>). This study demonstrated that this effect was dependent on myosin II and suggested that the increased motility was due to weakened cell adhesion and enhanced cell contractility. Rotty <italic>et al</italic> also found that the FcR phagocytic capability of CK-666 treated macrophages was similar to DMSO-treated controls. Extending this observation, we found that CK-869 but not CK-666 decreased the ability of macrophages to phagocytose zymosan compared to DMSO-treated controls (<xref ref-type="fig" rid="F3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4</xref>). Our observations in macrophages suggest that the ability of CK-666 to inhibit Arp2/3 dependent processes will depend on the relative expression of ArpC1A compared to ArpC1B, which will vary across cell types and tissues.</p></sec><sec id="S6"><title>CK-666 and CK-869 do not disrupt the Arp2/3 complex binding to F-actin or VCA</title><p id="P11">Structural data indicate that neither CK-666 nor CK-869 binds directly to the ArpC1 subunit (<xref ref-type="bibr" rid="R46">Nolen <italic>et al</italic>., 2009</xref>). The divergent effects of CK-666 on ArpC1A and ArpC1B within the Arp2/3 complex remains enigmatic. A possible explanation may be that the drugs affect the interaction between Arp2/3 iso-complexes and actin filaments indirectly. To investigate this, we performed actin filament co-sedimentation assays using ArpC1A and ArpC1B-containing complexes in the absence of VCA-mediated activation. We found that regardless of the presence of drugs, comparable quantities of ArpC1A and ArpC1B-containing Arp2/3 complexes co-pelleted with 3 or 15 μM actin filaments (<xref ref-type="fig" rid="F4">Figure 4A</xref>). This indicates that CK-666 and CK-869 do not impair the interaction between the Arp2/3 complex and actin filaments, in the context of different ArpC1 isoforms. However, when assays were performed with 3 μM F-actin, the level of ArpC1B/C5L co-pelleting with actin is a nearly twofold greater than complexes containing ArpC1A/C5L (<xref ref-type="fig" rid="F4">Figure 4A</xref>). This may in part explain why Arp2/3 complex with ArpC1B/C5L is a more efficient branch generator than those with ArpC1A/C5L (<xref ref-type="fig" rid="F2">Figure 2B</xref>) (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>., 2016</xref>).</p><p id="P12">Previous observations indicate that CK-666 and CK-869 do not impact VCA binding (<xref ref-type="bibr" rid="R26">Hetrick <italic>et al</italic>., 2013</xref>). However, in this study the Arp2/3 complex will be a mixture of iso-complexes as it was isolated from bovine brain (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>., 2016</xref>). We therefore performed GST-N-WASP-VCA pulldown assays to capture ArpC1A and ArpC1B containing complexes in the presence or absence of Arp2/3 inhibitors to determine if there are iso-complex specific differences. We found that the presence of either drug did not alter the quantity of ArpC1A- and ArpC1B-containing Arp2/3 complexes bound to GST-N-WASP-VCA (<xref ref-type="fig" rid="F4">Figure 4B</xref>). These results are consistent with previous observations, irrespective of the presence of distinct ArpC1 isoforms (<xref ref-type="bibr" rid="R26">Hetrick <italic>et al</italic>., 2013</xref>). It also suggests that inhibited and uninhibited Arp2/3 iso-complexes will compete for VCA binding in cells, which has important implications depending on the relative levels of ArpC1A and ArpC1B and which inhibitor is used. It would also explain why CK-666 inhibited ArpC1A complexes, which represent about a third of the total Arp2/3 in our HeLa cells (<xref ref-type="bibr" rid="R1">Abella <italic>et al</italic>., 2016</xref>), decreased virus induced actin polymerization by ~30% (<xref ref-type="fig" rid="F1">Figure 1B, C</xref>), even though Arp2/3 is in excess of N-WASP (<xref ref-type="bibr" rid="R25">Hein <italic>et al</italic>., 2015</xref>; <xref ref-type="bibr" rid="R35">Kulak <italic>et al</italic>., 2014</xref>).</p></sec><sec id="S7"><title>CK-666 inhibits activation of all Arp2/3 iso-complexes by SPIN90</title><p id="P13">As CK-666 inhibits ArpC1A, but not ArpC1B, containing Arp2/3 complexes from generating actin branches, we investigated whether the same is true when Arp2/3 is activated to form linear actin filaments by SPIN90. Pyrene assays demonstrate that CK-666 and CK-869 inhibit SPIN90-dependent actin polymerisation with a similar IC<sub>50</sub> irrespective of the ArpC1 isoform (<xref ref-type="fig" rid="F5">Figure 5A</xref> &amp; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5</xref>). We also observed by TIRF microscopy that both drugs inhibit actin filament formation by ArpC1A and ArpC1B containing Arp2/3 complexes activated by SPIN90, but only CK-869 completely blocked actin assembly (<xref ref-type="fig" rid="F5">Figure 5B</xref>).</p><p id="P14">Neither drug inhibited the interaction of Arp2/3 with SPIN90 in GST pull down assays (<xref ref-type="fig" rid="F5">Figure 5C</xref>). However, unexpectedly CK-869 promotes the binding of Arp2/3 to SPIN90, with the interaction with ArpC1A and ArpC1B containing complexes increasing ~15 and 5-fold respectively. There was also a slight increase in binding in the presence of CK-666. A possible explanation is that CK-869 blocks the Arp2/3 complex in an inactive state which favours binding to SPIN90 but prevents further conformational changes required for full activation which would subsequently weaken the association with SPIN90. This would imply that inactive Arp2/3 has a higher affinity for SPIN90 than the active complex as is observed for VCA but not cortactin NtA (<xref ref-type="bibr" rid="R37">Liu <italic>et al</italic>, 2024</xref>; <xref ref-type="bibr" rid="R78">Zimmet <italic>et al</italic>, 2020</xref>). This may explain why the amount of Arp2/3 pulled down with GST-SPIN90 is reduced in the presence of GST-N-WASP-VCA (<xref ref-type="bibr" rid="R8">Cao <italic>et al</italic>, 2023</xref>).</p></sec><sec id="S8"><title>CK-869 cannot inhibit Arp3B-containing complexes</title><p id="P15">Our results thus far demonstrate that CK-869 is a better inhibitor of Arp3-containing complexes than CK-666. To explore whether the same is also true for Arp3B containing complexes, we examined the impact of both inhibitors on the ability of Arp3B/ArpC1B/ArpC5L containing Arp2/3 complex to nucleate actin filaments. Quantification of actin assembly in TIRF assays reveals that the branching rates induced by GST-N-WASP-VCA in the presence of CK-666 were indistinguishable from DMSO-treated controls (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Unexpectedly, CK-869 no longer inhibits the Arp3B containing complex, which contrasts with our earlier observations using complexes with Arp3 (<xref ref-type="fig" rid="F2">Figure 2</xref>). Moreover, as observed with Arp3-containing complexes (<xref ref-type="fig" rid="F5">Figure 5</xref>), CK-666 inhibits the ability of SPIN90 to stimulate linear actin filament assembly by Arp3B-containing complexes (<xref ref-type="fig" rid="F6">Figure 6B</xref>). In sharp contrast, Arp3B-containing complexes efficiently generate linear actin filaments in the presence of CK-869. Our <italic>in vitro</italic> data demonstrate that CK-869 cannot inhibit Arp3B-containing complexes, even up to 250 μM in pyrene actin assembly assays (<xref ref-type="fig" rid="F6">Figure 6C</xref>).</p><p id="P16">Previous structural analysis reveals that CK-666 interacts mostly with Arp2 but forms two hydrophobic interactions with leucine 117 and threonine 119 of Arp3 (<xref ref-type="bibr" rid="R2">Baggett <italic>et al</italic>., 2012</xref>). These two residues are conserved in Arp3B, suggesting that the binding of CK-666 will be similar, which is consistent with our in vitro data. In contrast, several residues in the hydrophobic CK-869 binding pocket of Arp3 differ to those in Arp3B (<xref ref-type="bibr" rid="R26">Hetrick <italic>et al</italic>., 2013</xref>) (<xref ref-type="fig" rid="F6">Figure 6D</xref>). Notably, the leucine 126 in Arp3B may have direct clashes with CK-869 and preclude its binding leading to a loss of inhibition. A similar lack of inhibition due to non-conserved residues in the CK-869 binding pocket is also observed in Arp2/3 from budding and fission yeast (<xref ref-type="bibr" rid="R46">Nolen <italic>et al</italic>., 2009</xref>).</p></sec></sec><sec id="S9" sec-type="conclusions"><title>Conclusions</title><p id="P17">Using purified components and <italic>in vitro</italic> assays we have demonstrated that CK-666 can inhibit the formation of SPIN90-induced linear actin filaments by all Arp2/3 iso-complexes. However, CK-666 fails to suppress the initiation of actin branch formation by Arp2/3 complexes containing ArpC1B. In contrast, CK-869 prevents Arp3 but not Arp3B-containing complexes from generating both actin branches and linear actin filaments. Our results provide further evidence that Arp2/3 iso-complexes have different molecular properties. This observation also aligns with our cellular findings, where CK-869 exhibited greater efficacy in inhibiting vaccinia-induced actin assembly compared to CK-666. Examination of the literature reveals that most studies typically treat cells with CK-666 rather than CK-869, presumably because the latter is more toxic as it will result in complete loss of Arp2/3 function.</p><p id="P18">Our data demonstrate that both drugs have high affinity for Arp2/3 iso-complexes containing Arp3 (<xref ref-type="fig" rid="F5">Figure 5A</xref>). However, CK-666 and CK-869 have a different impact on Arp2/3 iso-complexes, depending on whether they are activated by VCA or SPIN90. Both drugs can effectively inhibit Arp2/3-SPIN90 generating actin filaments, while simultaneously enhancing, to varying degrees, the binding of Arp2/3 complexes to SPIN90. This implies that SPIN90 may induce a relatively weak activation of Arp2/3 complexes, which is more susceptible to inhibition. The observation that CK-666 has no discernible effect on the binding of Arp2/3 to either VCA or mother filaments indicates that CK-666 primarily disrupts the conformational changes of Arp2 and Arp3 to prevent complex activation as suggested by the structural data (<xref ref-type="bibr" rid="R2">Baggett <italic>et al</italic>., 2012</xref>). Nevertheless, ArpC1B but not ArpC1A containing complexes are able to adopt an activated conformation to generate actin branches on binding VCA even though they are bound to CK-666. This would suggest that the energy barrier between inactive and active conformations is lower for ArpC1B containing Arp2/3 complexes than those with ArpC1A. It is also possible that the conformation change required for activation displaces CK-666 from Arp2/3 iso-complexes containing ArpC1B. Structural analysis of Arp2/3 iso-complexes in transitional states of complex activation are required to fully understand their different behaviour.</p><p id="P19">The pivotal role of Arp2/3 complexes in many cellular processes that can become dysregulated in pathological conditions, highlights the ongoing need to screen for additional Arp2/3 inhibitors. Suppressing cancer cell migration and tumour metastasis, two ArpC2 binding inhibitors, were recently identified by revisiting FDA-approved drugs (<xref ref-type="bibr" rid="R11">Choi <italic>et al</italic>, 2019</xref>; <xref ref-type="bibr" rid="R77">Yoon <italic>et al</italic>, 2019</xref>). Several CK-666 structural analogues have been reported to have inhibitory effect on the Arp2/3 complex and two of them have better <italic>in vivo</italic> efficiency compared with CK-666 (<xref ref-type="bibr" rid="R21">Fokin <italic>et al</italic>, 2022</xref>). Given our results, it is possible that these drugs have different inhibitory effects on Arp2/3 iso-complexes. In summary, our results have important implications for the interpretation of experiments with CK-666 and CK-869 but also illuminate the potential utility of these inhibitors in exploring the cellular functions of specific Arp2/3 iso-complexes.</p></sec><sec id="S10" sec-type="materials | methods"><title>Materials and methods</title><sec id="S11"><title>Vaccinia virus infection and drug treatment</title><p id="P20">HeLa cells plated on fibronectin-coated coverslips were infected with Western Reserve Vaccinia virus in serum-free Minimum Essential Medium (MEM) at multiplicity of infection (MOI) = 2 (<xref ref-type="bibr" rid="R22">Frischknecht <italic>et al</italic>., 1999</xref>). After one hour at 37°C, the serum-free MEM was removed and replaced with complete MEM. At 8 hours post-infection, media was replaced with complete MEM containing CK-666 (Sigma, SML0006-5MG) or CK-869 (Sigma, C9124-5MG) or DMSO at desired concentrations for 1 hour prior to fixation.</p></sec><sec id="S12"><title>Immunofluorescence and actin tail quantification</title><p id="P21">As previously described (<xref ref-type="bibr" rid="R5">Basant &amp; Way, 2022</xref>), cells were fixed with 4% paraformaldehyde in PBS for 10 min, blocked in cytoskeletal buffer (1 mM MES, 15 mM NaCl, 0.5 mM EGTA, 0.5 mM MgCl<sub>2</sub>, and 0.5 mM glucose, pH 6.1) containing 2% (vol/vol) fetal calf serum and 1% (wt/vol) BSA for 30 min. To visualize extra-cellular vaccinia virus particles, prior to permeabilization with detergent, the cells were stained with a monoclonal antibody against B5 (19C2, rat, 1:1000 (<xref ref-type="bibr" rid="R61">Schmelz <italic>et al</italic>, 1994</xref>)) followed by an Alexa Fluor 647 anti-rat secondary antibody (Invitrogen; 1:1000 in blocking buffer). Cells were then permeabilized with 0.1% Triton-X/PBS for 3 min. Branched actin was labelled with cortactin monoclonal antibody (Millipore (p80/85); 1:400), followed by Alexa Fluor 488 conjugated secondary antibody (Invitrogen; 1:1000 in blocking buffer). Actin filaments were labelled with Alexa Fluor 568 phalloidin (Invitrogen; 1:500). Coverslips were mounted on glass slides using Mowiol (Sigma) and imaged on a Zeiss Axioplan2 microscope equipped with a 63x/1.4 NA. Plan-Achromat objective and a Photometrics Cool Snap HQ cooled charge-coupled device camera. The microscope was controlled with MetaMorph 7.8.13.0 software. Quantification of branched actin induced by vaccinia virus was performed using two-colour fixed cell images where cortactin and extracellular virus were labelled. Ten cells were analysed per condition in three independent experiments. Fifteen isolated extracellular virus particles were blindly selected in each image and the presence of actin and cortactin at the virus was determined in the corresponding channels.</p></sec><sec id="S13"><title>Bone marrow-derived macrophage migration and phagocytosis</title><p id="P22">All animal work was authorized by UK Home Office project license P7E080263 and personal licenses following the approval by the Animal Welfare and Ethical Review Body of The Francis Crick Institute. Murine bone marrow was extracted from tibia and femur of C57BL/6Jax mice and differentiated <italic>in vitro</italic> for 7 days in macrophage conditional medium (RPMI supplemented with 30% L929 conditioned medium, 20% FBS and 1% P/S) to obtain bone marrow-derived macrophages (BMDM).</p><p id="P23">To examine the effects of different inhibitors on cell morphology and migration, BMDM were seeded in 24-well glass bottomed plates (Cellvis) at 1*10<sup>4</sup> cells/well in 500 μL of macrophage conditional medium. Cells were imaged and analyzed using the Livecyte system (Phasefocus) every 10 mins for 24 h at 10 x with two fields of view per well. The imaging chamber was maintained at 37°C with 5% CO<sub>2</sub>. Meanwhile, cells were seeded at 2 *10<sup>4</sup> cells/well in Glass-bottomed 8-well μ-Slides (ibidi) and imaged using an inverted widefield Nikon Ti2 Eclipse long-term time lapse system with an LED illumination system. The imaging chamber was maintained at 37°C with 5% CO<sub>2</sub>. A Nikon 20× Ph2 planar (plan) apochromatic (apo) (0.75 N.A.) air objective was used to acquire images at a single <italic>z</italic>-slice every 10 min for 5 hours with two fields of view per well. Livecyte automatically quantified the motility and the morphology of macrophages by measuring their moving speed as well as their thickness and their length/width ratio. For each condition, more than 30 cells were quantified. The experiments were repeated five times independently.</p><p id="P24">To assess the effects of different inhibitors on phagocytosis, BMDM were seeded in 96-well V-bottom plates (Corning) at 1*10<sup>5</sup> cells/well in 100 μL macrophage conditional medium supplemented with different inhibitors or DMSO as indicated. BMDM were incubated with 25 μg/mL pHrodo zymosan bio-particles (Invitrogen) for up to 120 min at 37°C, 5% CO<sub>2</sub>. Cells were then washed with PBS and stained with an antibody cocktail (Live/Dead Fixable Violet Dead Cell Stain (1:500, Invitrogen), CD11b-BV711 (1:100, BioLegend), F4/80-APC (1:100, eBiosciences)) to identify the live BMDM. Samples were then assessed by flow cytometry and the phagocytic fraction indicated the % of (BMDM internalized the zymosan bio-particles) / (Total BMDM).</p></sec><sec id="S14"><title>Protein purification and preparation</title><p id="P25">GST-tagged human N-WASP-VCA (392 – 505, UniProt O00401), human SPIN90 C-terminus (267 - 715, UniProt Q9NZQ3-3), were purified as previously reported (<xref ref-type="bibr" rid="R8">Cao <italic>et al</italic>., 2023</xref>). Recombinant human Arp2/3 iso-complexes with defined composition (Uniprot P61160, P61158, Q9P1U1, Q92747, O15143, O15144, O15145, P59998, Q9H9F9, Q98PX5) were purified as previously reported (<xref ref-type="bibr" rid="R4">Baldauf <italic>et al</italic>, 2023</xref>). Skeletal muscle alpha-actin was purified from rabbit muscle acetone powder following the published protocol (<xref ref-type="bibr" rid="R67">Spudich &amp; Watt, 1971</xref>). Actin was fluorescently labelled on the surface lysine 328, using Alexa-488 or Alexa-594 succinimidyl ester (Life Technologies) as previously reported (<xref ref-type="bibr" rid="R54">Romet-Lemonne <italic>et al</italic>, 2018</xref>). Pyrenyl-actin was made by labelling actin with N(1-pyrene)-iodoacetamide (Thermo Fisher Scientific) (<xref ref-type="bibr" rid="R13">Cooper <italic>et al</italic>, 1983</xref>). To mimic the use of drugs in cells, Arp2/3 iso-complexes were incubated with 100 μM CK-666 or CK-869 (Sigma, Bio-Techne), or equivalent amount of DMSO at room temperature for 1 hour before being used in in vitro assays.</p></sec><sec id="S15"><title>Pyrene actin polymerisation assay</title><p id="P26">Actin polymerisation induced by Arp2/3 and NPF I is very fast. To have a good resolution, 2 nM Arp2/3 iso-complexes, 5 nM GST-N-WASP-VCA and 2 μM G-actin (5% pyrene labelled) was mixed and measured in a Safas Xenius fluorimeter at room temperature (<xref ref-type="bibr" rid="R69">von Loeffelholz <italic>et al</italic>., 2020</xref>). The negative control experiment was done without GST-N-WASP-VCA. For experiments with SPIN90, the same concentration of Arp2/3 iso-complexes was used together with 100 nM SPIN90-Cter and 2.5 μM G-actin (5% pyrene labelled). The negative control for these experiments lacked SPIN90-Cter. All actin assembly assays above were performed in a buffer containing 5 mM Tris HCl pH 7.0, 50 mM KCl, 0.2 mM ATP, 1 mM MgCl<sub>2</sub>, 1 mM EGTA and 1 mM DTT in addition to 100 μM CK-666 or CK-869 or equivalent amount of DMSO. To quantify IC<sub>50</sub> values, Arp2/3 iso-complexes were incubated with DMSO or different drug concentrations for 1 hour. Then 2 nM drug treated Arp2/3 iso-complexes were mixed with 10 nM VCA or 400 nM SPIN90-Cter together with 2.5 μM G-actin (5% pyrene labelled) in the presence of the same concentration of drugs. The experimental buffer contains 5 mM Tris HCl pH 7.0, 50 mM KCl, 1 mM MgCl<sub>2</sub>, 0.2 mM EGTA, 0.2 mM ATP, 10 mM DTT, 1 mM DABCO at room temperature. The maximum polymerisation rate of each pyrene curve was measured and plotted versus defined drug concentration.</p></sec><sec id="S16"><title>TIRF assays</title><p id="P27">Deep UV treated coverslips were passivated by mPEG silane overnight. The coverslips were rinsed thoroughly with ethanol and water. Before experiments, dried coverslips were stuck to the glass slides with 3 mm-separated parafilm bands to create flow chambers. The experiments were performed in TIRF buffer: 5 mM Tris HCl pH 7.0, 50 mM KCl, 1 mM MgCl<sub>2</sub>, 0.2 mM EGTA, 0.2 mM ATP, 10 mM DTT, 1 mM DABCO, 0.1% BSA and 0.3% Methylcellulose 4000 cP at 25 °C.</p><p id="P28">Actin branching assays were performed as previously described (<xref ref-type="bibr" rid="R10">Cao <italic>et al</italic>., 2020</xref>). To quantify the branching efficiency, 2.5 μM G-actin (15% Alexa-488 labelled) was pre-incubated in experimental buffer at room temperature for 1 hour to form fluorescent actin filaments. During experiment, 25 nM pre-polymerised actin (15% Alexa-488 labelled) was mixed with 25 nM GST-N-WASP-VCA, 0.5 μM profilin, 2 nM of 1 hour inhibitor-treated Arp2/3 in addition to defined concentration of CK-666 or CK-869 (final concentration) or equivalent amount of DMSO. G-actin (0.5 μM, 15 % Alexa-568 labelled) was added to the system at the last moment. Then the mixture was immediately flowed into the chamber for imaging. The moment when G-actin added into the system was recorded as time 0. Branch generation was observed over time. The number of branches generated per μm of actin filaments per minute was quantified as the branching rate. The quantified branching rates versus defined drug concentrations were plotted to determine the IC<sub>50</sub>. To study the actin nucleation by SPIN90, the 25 nM GST-N-WASP-VCA was replaced 200 nM SPIN90-Cter and 20 nM of inhibitor treated Arp2/3 were used as in the same protocol as above.</p><p id="P29">Actin branching rate in TIRF assay was quantified by counting the number of generated branches per μm length of actin mother filament per second using Fiji software (<xref ref-type="bibr" rid="R60">Schindelin <italic>et al</italic>, 2012</xref>). In each condition, the ten longest mother filaments were chosen to analyse. Three independent repeats were performed. Actin nucleation by SPIN90-Arp2/3 complex in TIRF assay was quantified by measuring the filament density of a randomly picked field of view (59 μm x 59 μm) at 240s. Three independent repeats were performed.</p></sec><sec id="S17"><title>GST pull down assays</title><p id="P30">Prior to performing pull-down assays, the Glutathione Sepharose™ 4B resin (GE Healthcare) was incubated with 5% BSA for 5 minutes and washed 3 times with GST pull-down buffer containing 50 mM Tris-HCl pH 7.0, 1 mM MgCl<sub>2</sub>, 0.2 mM EGTA, 0.2 mM ATP, 1 mM DTT, 50 mM KCl, and 5% glycerol. Glutathione Sepharose 4B beads were mixed with 50 μL of 5 μM GST-SPIN90-Cter or GST-N-WASP-VCA, 200 nM drug treated Arp2/3 in addition to 100 μM inhibitor or equivalent amount of DMSO. After 1 hour incubation at room temperature, the resin was then washed 3 times with 300 μL of GST pull-down buffer. The proteins bound to the resin were eluted with 50 μL of 50 mM GSH (reduced glutathione). The sample was analysed by SDS-PAGE followed by western blot using Anti-ArpC2 (Sigma) to detect Arp2/3 complexes. Amersham imager AI600 was used to develop the western blot results. The amount of GST- tagged protein eluted from the resin was detected by ponceau. The negative control experiment was done in the same way except 50 μL of 5 μM Glutathione Sepharose™ 4B attached GST was used instead of GST-SPIN90-Cter or GST-N-WASP-VCA.</p></sec><sec id="S18"><title>F-Actin co-sedimentation assays</title><p id="P31">G-actin was incubated in F-buffer (5 mM Tris pH 7.0, 100 mM KCl, 0.2 mM ATP, 1 mM MgCl<sub>2</sub>, and 1 mM DTT) at room temperature for 1 hour before 3 μM or 15 μM of the polymerised actin filaments were mixed with 4 μM inhibitor treated Arp2/3 iso-complexes in F-buffer in the presence of 100 μM CK-666 or CK-869 or equivalent amount of DMSO at room temperature for 1 hour. The supernatant and pellet were then separated by ultracentrifuge at 70000 rpm at 25 °C for 30 minutes. Pellet was resuspended with 50 μL of F-buffer and the same amount (20 μL) of supernatant and pellet was loaded on a SDS page. The negative control only has Arp2/3 iso-complexes without F-actin. Fiji software was used to quantify the Coomassie blue gels (<xref ref-type="bibr" rid="R60">Schindelin <italic>et al</italic>, 2012</xref>).</p></sec><sec id="S19"><title>Protein structure analysis</title><p id="P32">Pymol is used to visualize and analyse the structure of drug bound Arp2/3 complex (Schrodinger, 2010). Potential Van-der-Waals clashes were detected by show bumps plugin.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary figures 1 to 5</label><media xlink:href="EMS191787-supplement-Supplementary_figures_1_to_5.pdf" mimetype="application" mime-subtype="pdf" id="d21aAdEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Material</label><media xlink:href="EMS191787-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d21aAdEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S20"><title>Acknowledgements</title><p>This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 810207 to Michael Way. Luyan Cao was supported by the European Union’s Horizon 2020 Marie Sklodowka-Curie individual fellowship program (H2020-MSCA-IF-101028239 – MolecularArp) and the ERC Synergy grant (No 810207). MW is additionally supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (CC2096), the UK Medical Research Council (CC2096), and the Wellcome Trust (CC2096). We thank Carolyn Moores (Birkbeck, University of London), Snezhka Oliferenko &amp; Jeremy Carlton (the Francis Crick Institute, London) and Guillaume Romet-Lemonne &amp; Antoine Jegou (Institut Jacques Monod, Paris) for feedback on the manuscript. For the purpose of Open Access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</p></ack><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abella</surname><given-names>JV</given-names></name><name><surname>Galloni</surname><given-names>C</given-names></name><name><surname>Pernier</surname><given-names>J</given-names></name><name><surname>Barry</surname><given-names>DJ</given-names></name><name><surname>Kjaer</surname><given-names>S</given-names></name><name><surname>Carlier</surname><given-names>MF</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Isoform diversity in the Arp2/3 complex détermines actin filament dynamics</article-title><source>Nat Cell Biol</source><year>2016</year><volume>18</volume><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">26655834</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggett</surname><given-names>AW</given-names></name><name><surname>Cournia</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>MS</given-names></name><name><surname>Patargias</surname><given-names>G</given-names></name><name><surname>Glass</surname><given-names>AC</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><name><surname>Nolen</surname><given-names>BJ</given-names></name></person-group><article-title>Structural characterization and computer-aided optimization of a small-molecule inhibitor of the Arp2/3 complex, a key regulator of the actin cytoskeleton</article-title><source>ChemMedChem</source><year>2012</year><volume>7</volume><fpage>1286</fpage><lpage>1294</lpage><pub-id pub-id-type="pmcid">PMC3531959</pub-id><pub-id pub-id-type="pmid">22623398</pub-id><pub-id pub-id-type="doi">10.1002/cmdc.201200104</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>MK</given-names></name><name><surname>Feoktistova</surname><given-names>A</given-names></name><name><surname>McCollum</surname><given-names>D</given-names></name><name><surname>Gould</surname><given-names>KL</given-names></name></person-group><article-title>Fission yeast Sop2p: a novel and evolutionarily conserved protein that interacts with Arp3p and modulates profilin function</article-title><source>EMBO J</source><year>1996</year><volume>15</volume><fpage>6426</fpage><lpage>6437</lpage><pub-id pub-id-type="pmcid">PMC452468</pub-id><pub-id pub-id-type="pmid">8978670</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldauf</surname><given-names>L</given-names></name><name><surname>Frey</surname><given-names>F</given-names></name><name><surname>Arribas Perez</surname><given-names>M</given-names></name><name><surname>Idema</surname><given-names>T</given-names></name><name><surname>Koenderink</surname><given-names>GH</given-names></name></person-group><article-title>Branched actin cortices reconstituted in vesicles sense membrane curvature</article-title><source>Biophys J</source><year>2023</year><volume>122</volume><fpage>2311</fpage><lpage>2324</lpage><pub-id pub-id-type="pmcid">PMC10257126</pub-id><pub-id pub-id-type="pmid">36806830</pub-id><pub-id pub-id-type="doi">10.1016/j.bpj.2023.02.018</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basant</surname><given-names>A</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>The relative binding position of Nck and Grb2 adaptors impacts actin-based motility of Vaccinia virus</article-title><source>Elife</source><year>2022</year><volume>11</volume><elocation-id>e74655</elocation-id><pub-id pub-id-type="pmcid">PMC9333988</pub-id><pub-id pub-id-type="pmid">35796545</pub-id><pub-id pub-id-type="doi">10.7554/eLife.74655</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basant</surname><given-names>A</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>The amount of Nck rather than N-WASP correlates with the rate of actin-based motility of Vaccinia virus</article-title><source>Microbiol Spectr</source><year>2023</year><volume>11</volume><elocation-id>e0152923</elocation-id><pub-id pub-id-type="pmcid">PMC10883800</pub-id><pub-id pub-id-type="pmid">37855608</pub-id><pub-id pub-id-type="doi">10.1128/spectrum.01529-23</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigida</surname><given-names>I</given-names></name><name><surname>Zoccolillo</surname><given-names>M</given-names></name><name><surname>Cicalese</surname><given-names>MP</given-names></name><name><surname>Pfajfer</surname><given-names>L</given-names></name><name><surname>Barzaghi</surname><given-names>F</given-names></name><name><surname>Scala</surname><given-names>S</given-names></name><name><surname>Oleaga-Quintas</surname><given-names>C</given-names></name><name><surname>Alvarez-Alvarez</surname><given-names>JA</given-names></name><name><surname>Sereni</surname><given-names>L</given-names></name><name><surname>Giannelli</surname><given-names>S</given-names></name><etal/></person-group><article-title>T-cell defects in patients with ARPC1B germline mutations account for combined immunodeticiency</article-title><source>Blood</source><year>2018</year><volume>132</volume><fpage>2362</fpage><lpage>2374</lpage><pub-id pub-id-type="pmcid">PMC6265646</pub-id><pub-id pub-id-type="pmid">30254128</pub-id><pub-id pub-id-type="doi">10.1182/blood-2018-07-863431</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Ghasemi</surname><given-names>F</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><name><surname>Jegou</surname><given-names>A</given-names></name><name><surname>Romet-Lemonne</surname><given-names>G</given-names></name></person-group><article-title>Regulation of branched versus linear Arp2/3-generated actin filaments</article-title><source>EMBO J</source><year>2023</year><volume>42</volume><elocation-id>e113008</elocation-id><pub-id pub-id-type="pmcid">PMC10152144</pub-id><pub-id pub-id-type="pmid">36939020</pub-id><pub-id pub-id-type="doi">10.15252/embj.2022113008</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>The stabilization of Arp2/3 complex generated actin filaments</article-title><source>Biochem Soc Trans</source><year>2024</year><volume>52</volume><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="pmcid">PMC10903444</pub-id><pub-id pub-id-type="pmid">38288872</pub-id><pub-id pub-id-type="doi">10.1042/BST20230638</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Yonis</surname><given-names>A</given-names></name><name><surname>Vaghela</surname><given-names>M</given-names></name><name><surname>Barriga</surname><given-names>EH</given-names></name><name><surname>Chugh</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>MB</given-names></name><name><surname>Maufront</surname><given-names>J</given-names></name><name><surname>Lavoie</surname><given-names>G</given-names></name><name><surname>Meant</surname><given-names>A</given-names></name><name><surname>Ferber</surname><given-names>E</given-names></name><etal/></person-group><article-title>SPIN90 associates with mDia1 and the Arp2/3 complex to regulate cortical actin organization</article-title><source>Nat Cell Biol</source><year>2020</year><volume>22</volume><fpage>803</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">32572169</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Doo Kim</surname><given-names>N</given-names></name><name><surname>Cho Han</surname><given-names>D</given-names></name><name><surname>Kwon</surname><given-names>BM</given-names></name></person-group><article-title>Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex</article-title><source>Cancer Sci</source><year>2019</year><volume>110</volume><fpage>3788</fpage><lpage>3801</lpage><pub-id pub-id-type="pmcid">PMC6890432</pub-id><pub-id pub-id-type="pmid">31571309</pub-id><pub-id pub-id-type="doi">10.1111/cas.14205</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>SZ</given-names></name><name><surname>Chatterjee</surname><given-names>M</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>Mechanism of actin filament branch formation by Arp2/3 complex revealed by a high-resolution cryo-EM structureof the branch junction</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><volume>119</volume><elocation-id>e2206722119</elocation-id><pub-id pub-id-type="pmcid">PMC9894260</pub-id><pub-id pub-id-type="pmid">36442092</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2206722119</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Walker</surname><given-names>SB</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>Pyrene actin: documentation of the validity of a sensitive assay for actin polymerization</article-title><source>J Muscle Res Cell Motil</source><year>1983</year><volume>4</volume><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">6863518</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cudmore</surname><given-names>S</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name><name><surname>Griffiths</surname><given-names>G</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Actin-based motility of vaccinia virus</article-title><source>Nature</source><year>1995</year><volume>378</volume><fpage>636</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">8524400</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cudmore</surname><given-names>S</given-names></name><name><surname>Reckmann</surname><given-names>I</given-names></name><name><surname>Griffiths</surname><given-names>G</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Vaccinia virus: a model system for actin-membrane interactions</article-title><source>J CellSci</source><year>1996</year><volume>109</volume><fpage>1739</fpage><lpage>1747</lpage><pub-id pub-id-type="pmid">8832396</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Narvaez-Ortiz</surname><given-names>HY</given-names></name><name><surname>Singh</surname><given-names>Y</given-names></name><name><surname>Hocky</surname><given-names>GM</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><name><surname>Nolen</surname><given-names>BJ</given-names></name></person-group><article-title>Structure of Arp2/3 complex at a branched actin filament junction resolved by single-particle cryo-electron microscopy</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><volume>119</volume><elocation-id>e2202723119</elocation-id><pub-id pub-id-type="pmcid">PMC9295785</pub-id><pub-id pub-id-type="pmid">35622886</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2202723119</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>SK</given-names></name><name><surname>Weisswange</surname><given-names>I</given-names></name><name><surname>Zettl</surname><given-names>M</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>WIP provides an essential link between Nck and N-WASP during Arp2/3-dependent actin polymerization</article-title><source>Curr Biol</source><year>2013</year><volume>23</volume><fpage>999</fpage><lpage>1006</lpage><pub-id pub-id-type="pmcid">PMC3690476</pub-id><pub-id pub-id-type="pmid">23707428</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2013.04.051</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinoza-Sanchez</surname><given-names>S</given-names></name><name><surname>Metskas</surname><given-names>LA</given-names></name><name><surname>Chou</surname><given-names>SZ</given-names></name><name><surname>Rhoades</surname><given-names>E</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>Conformational changes in Arp2/3 complex induced by ATP, WASp-VCA, and actin filaments</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>E8642</fpage><lpage>E8651</lpage><pub-id pub-id-type="pmcid">PMC6140485</pub-id><pub-id pub-id-type="pmid">30150414</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1717594115</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fassler</surname><given-names>F</given-names></name><name><surname>Dimchev</surname><given-names>G</given-names></name><name><surname>Hodirnau</surname><given-names>VV</given-names></name><name><surname>Wan</surname><given-names>W</given-names></name><name><surname>Schur</surname><given-names>FKM</given-names></name></person-group><article-title>Cryo-electron tomography structure of Arp2/3 complex in cells reveals new insights into the branch junction</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>6437</elocation-id><pub-id pub-id-type="pmcid">PMC7755917</pub-id><pub-id pub-id-type="pmid">33353942</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-20286-x</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fassler</surname><given-names>F</given-names></name><name><surname>Javoor</surname><given-names>MG</given-names></name><name><surname>Datler</surname><given-names>J</given-names></name><name><surname>Doring</surname><given-names>H</given-names></name><name><surname>Hofer</surname><given-names>FW</given-names></name><name><surname>Dimchev</surname><given-names>G</given-names></name><name><surname>Hodirnau</surname><given-names>VV</given-names></name><name><surname>Faix</surname><given-names>J</given-names></name><name><surname>Rottner</surname><given-names>K</given-names></name><name><surname>Schur</surname><given-names>FKM</given-names></name></person-group><article-title>ArpC5 isoforms regulate Arp2/3 complex-dependent protrusion through differential Ena/VASP positioning</article-title><source>Sci Adv</source><year>2023</year><volume>9</volume><elocation-id>eadd6495</elocation-id><pub-id pub-id-type="pmcid">PMC9858492</pub-id><pub-id pub-id-type="pmid">36662867</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.add6495</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fokin</surname><given-names>AI</given-names></name><name><surname>Chuprov-Netochin</surname><given-names>RN</given-names></name><name><surname>Malyshev</surname><given-names>AS</given-names></name><name><surname>Romero</surname><given-names>S</given-names></name><name><surname>Semenova</surname><given-names>MN</given-names></name><name><surname>Konyushkin</surname><given-names>LD</given-names></name><name><surname>Leonov</surname><given-names>SV</given-names></name><name><surname>Semenov</surname><given-names>VV</given-names></name><name><surname>Gautreau</surname><given-names>AM</given-names></name></person-group><article-title>Synthesis, Screening and Characterization of Novel Potent Arp2/3 Inhibitory Compounds Analogous to CK-666</article-title><source>Front Pharmacol</source><year>2022</year><volume>13</volume><elocation-id>896994</elocation-id><pub-id pub-id-type="pmcid">PMC9189929</pub-id><pub-id pub-id-type="pmid">35707404</pub-id><pub-id pub-id-type="doi">10.3389/fphar.2022.896994</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frischknecht</surname><given-names>F</given-names></name><name><surname>Moreau</surname><given-names>V</given-names></name><name><surname>Rottger</surname><given-names>S</given-names></name><name><surname>Gonfloni</surname><given-names>S</given-names></name><name><surname>Reckmann</surname><given-names>I</given-names></name><name><surname>Superti-Furga</surname><given-names>G</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>926</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">10553910</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galloni</surname><given-names>C</given-names></name><name><surname>Carra</surname><given-names>D</given-names></name><name><surname>Abella</surname><given-names>JVG</given-names></name><name><surname>Kjaer</surname><given-names>S</given-names></name><name><surname>Singaravelu</surname><given-names>P</given-names></name><name><surname>Barry</surname><given-names>DJ</given-names></name><name><surname>Kogata</surname><given-names>N</given-names></name><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Blanchoin</surname><given-names>L</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>MICAL2 enhances branched actin network disassembly by oxidizing Arp3B-containing Arp2/3 complexes</article-title><source>J Cell Biol</source><year>2021</year><volume>220</volume><elocation-id>e202102043</elocation-id><pub-id pub-id-type="pmcid">PMC8193582</pub-id><pub-id pub-id-type="pmid">34106209</pub-id><pub-id pub-id-type="doi">10.1083/jcb.202102043</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautreau</surname><given-names>AM</given-names></name><name><surname>Fregoso</surname><given-names>FE</given-names></name><name><surname>Simanov</surname><given-names>G</given-names></name><name><surname>Dominguez</surname><given-names>R</given-names></name></person-group><article-title>Nucleation, stabilization, and disassembly of branched actin networks</article-title><source>Trends Cell Biol</source><year>2022</year><volume>32</volume><fpage>421</fpage><lpage>432</lpage><pub-id pub-id-type="pmcid">PMC9018471</pub-id><pub-id pub-id-type="pmid">34836783</pub-id><pub-id pub-id-type="doi">10.1016/j.tcb.2021.10.006</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Hubner</surname><given-names>NC</given-names></name><name><surname>Poser</surname><given-names>I</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Toyoda</surname><given-names>Y</given-names></name><name><surname>Gak</surname><given-names>IA</given-names></name><name><surname>Weisswange</surname><given-names>I</given-names></name><name><surname>Mansfeld</surname><given-names>J</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><etal/></person-group><article-title>A human interactome in three quantitative dimensions organized by stoichiometries and abundances</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>712</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">26496610</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetrick</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>MS</given-names></name><name><surname>Helgeson</surname><given-names>LA</given-names></name><name><surname>Nolen</surname><given-names>BJ</given-names></name></person-group><article-title>Small molecules CK-666 and CK-869 inhibit actin-related protein 2/3 complex by blocking an activating conformational change</article-title><source>Chem Biol</source><year>2013</year><volume>20</volume><fpage>701</fpage><lpage>712</lpage><pub-id pub-id-type="pmcid">PMC3684959</pub-id><pub-id pub-id-type="pmid">23623350</pub-id><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.03.019</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinze</surname><given-names>C</given-names></name><name><surname>Boucrot</surname><given-names>E</given-names></name></person-group><article-title>Local actin polymerization during endocytic carrier formation</article-title><source>Biochem Soc Trans</source><year>2018</year><volume>46</volume><fpage>565</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">29678956</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollinshead</surname><given-names>M</given-names></name><name><surname>Rodger</surname><given-names>G</given-names></name><name><surname>Van Eijl</surname><given-names>H</given-names></name><name><surname>Law</surname><given-names>M</given-names></name><name><surname>Hollinshead</surname><given-names>R</given-names></name><name><surname>Vaux</surname><given-names>DJ</given-names></name><name><surname>Smith</surname><given-names>GL</given-names></name></person-group><article-title>Vaccinia virus utilizes microtubules for movement to the cell surface</article-title><source>J Cell Biol</source><year>2001</year><volume>154</volume><fpage>389</fpage><lpage>402</lpage><pub-id pub-id-type="pmcid">PMC2150758</pub-id><pub-id pub-id-type="pmid">11470826</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200104124</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname><given-names>AC</given-names></name><name><surname>Donnelly</surname><given-names>SK</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Cdc42 and the Rho GEF intersectin-1 collaborate with Nck to promote N-WASP-dependent actin polymerisation</article-title><source>J Cell Sci</source><year>2014</year><volume>127</volume><fpage>673</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">24284073</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>P</given-names></name><name><surname>Berge-Lefranc</surname><given-names>JL</given-names></name><name><surname>Massacrier</surname><given-names>A</given-names></name><name><surname>Roessler</surname><given-names>E</given-names></name><name><surname>Wallis</surname><given-names>D</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name><name><surname>Gastaldi</surname><given-names>M</given-names></name><name><surname>Taviaux</surname><given-names>S</given-names></name><name><surname>Cau</surname><given-names>P</given-names></name><name><surname>Berta</surname><given-names>P</given-names></name></person-group><article-title>ARP3beta, the gene encoding a new human actin-related protein, is alternatively spliced and predominantly expressed in brain neuronal cells</article-title><source>Eur J Biochem</source><year>2000</year><volume>267</volume><fpage>2921</fpage><lpage>2928</lpage><pub-id pub-id-type="pmid">10806390</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahr</surname><given-names>WH</given-names></name><name><surname>Pluthero</surname><given-names>FG</given-names></name><name><surname>Elkadri</surname><given-names>A</given-names></name><name><surname>Warner</surname><given-names>N</given-names></name><name><surname>Drobac</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Lo</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><elocation-id>14816</elocation-id><pub-id pub-id-type="pmcid">PMC5382316</pub-id><pub-id pub-id-type="pmid">28368018</pub-id><pub-id pub-id-type="doi">10.1038/ncomms14816</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Mear</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Digre</surname><given-names>A</given-names></name><name><surname>Katona</surname><given-names>B</given-names></name><name><surname>Sjostedt</surname><given-names>E</given-names></name><name><surname>Butler</surname><given-names>L</given-names></name><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Dusart</surname><given-names>P</given-names></name><etal/></person-group><article-title>A single-cell type transcriptomics map of human tissues</article-title><source>Sci Adv</source><year>2021</year><volume>7</volume><elocation-id>eabh2169</elocation-id><pub-id pub-id-type="pmcid">PMC8318366</pub-id><pub-id pub-id-type="pmid">34321199</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abh2169</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Pinto</surname><given-names>SM</given-names></name><name><surname>Getnet</surname><given-names>D</given-names></name><name><surname>Nirujogi</surname><given-names>RS</given-names></name><name><surname>Manda</surname><given-names>SS</given-names></name><name><surname>Chaerkady</surname><given-names>R</given-names></name><name><surname>Madugundu</surname><given-names>AK</given-names></name><name><surname>Kelkar</surname><given-names>DS</given-names></name><name><surname>Isserlin</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><etal/></person-group><article-title>A draft map of the human proteome</article-title><source>Nature</source><year>2014</year><volume>509</volume><fpage>575</fpage><lpage>581</lpage><pub-id pub-id-type="pmcid">PMC4403737</pub-id><pub-id pub-id-type="pmid">24870542</pub-id><pub-id pub-id-type="doi">10.1038/nature13302</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Tool</surname><given-names>ATJ</given-names></name><name><surname>van der Bijl</surname><given-names>I</given-names></name><name><surname>de Boer</surname><given-names>M</given-names></name><name><surname>van Houdt</surname><given-names>M</given-names></name><name><surname>de Cuyper</surname><given-names>IM</given-names></name><name><surname>Roos</surname><given-names>D</given-names></name><name><surname>van Alphen</surname><given-names>F</given-names></name><name><surname>van Leeuwen</surname><given-names>K</given-names></name><name><surname>Cambridge</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency</article-title><source>J Allergy Clin Immunol</source><year>2017</year><volume>140</volume><fpage>273</fpage><lpage>277</lpage><elocation-id>e210</elocation-id><pub-id pub-id-type="pmid">27965109</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulak</surname><given-names>NA</given-names></name><name><surname>Pichler</surname><given-names>G</given-names></name><name><surname>Paron</surname><given-names>I</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><article-title>Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells</article-title><source>Nat Methods</source><year>2014</year><volume>11</volume><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">24487582</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname><given-names>F</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>The role of signalling and the cytoskeleton during Vaccinia Virus egress</article-title><source>Virus Res</source><year>2015</year><volume>209</volume><fpage>87</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">25681743</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Mladenov</surname><given-names>M</given-names></name><name><surname>Jegou</surname><given-names>A</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><name><surname>Moores</surname><given-names>CA</given-names></name></person-group><article-title>Cortactin stabilizes actin branches by bridging activated Arp2/3 to its nucleated actin filament</article-title><source>Nat Struct Mol Biol</source><year>2024</year><comment>Online ahead of print</comment><pub-id pub-id-type="pmid">38267598</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luan</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>SL</given-names></name><name><surname>Helgeson</surname><given-names>LA</given-names></name><name><surname>Nolen</surname><given-names>BJ</given-names></name></person-group><article-title>Structure of the nucleation-promoting factor SPIN90 bound to the actin filament nucleator Arp2/3 complex</article-title><source>EMBO J</source><year>2018</year><volume>37</volume><elocation-id>e100005</elocation-id><pub-id pub-id-type="pmcid">PMC6236337</pub-id><pub-id pub-id-type="pmid">30322896</pub-id><pub-id pub-id-type="doi">10.15252/embj.2018100005</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machesky</surname><given-names>LM</given-names></name><name><surname>Reeves</surname><given-names>E</given-names></name><name><surname>Wientjes</surname><given-names>F</given-names></name><name><surname>Mattheyse</surname><given-names>FJ</given-names></name><name><surname>Grogan</surname><given-names>A</given-names></name><name><surname>Totty</surname><given-names>NF</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Hsuan</surname><given-names>JJ</given-names></name><name><surname>Segal</surname><given-names>AW</given-names></name></person-group><article-title>Mammalian actin-related protein 2/3 complex localizes to regions of lamellipodial protrusion and is composed of evolutionarily conserved proteins</article-title><source>Biochem J</source><year>1997</year><volume>328</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmcid">PMC1218893</pub-id><pub-id pub-id-type="pmid">9359840</pub-id><pub-id pub-id-type="doi">10.1042/bj3280105</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millard</surname><given-names>TH</given-names></name><name><surname>Behrendt</surname><given-names>B</given-names></name><name><surname>Launay</surname><given-names>S</given-names></name><name><surname>Futterer</surname><given-names>K</given-names></name><name><surname>Machesky</surname><given-names>LM</given-names></name></person-group><article-title>Identification and characterisation of a novel human isoform of Arp2/3 complex subunit p16-ARC/ARPC5</article-title><source>Cell Motil Cytoskeleton</source><year>2003</year><volume>54</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12451597</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinie</surname><given-names>N</given-names></name><name><surname>Gautreau</surname><given-names>A</given-names></name></person-group><article-title>The Arp2/3 Regulatory System and Its Deregulation in Cancer</article-title><source>Physiol Rev</source><year>2018</year><volume>98</volume><fpage>215</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">29212790</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinie</surname><given-names>N</given-names></name><name><surname>Rubtsova</surname><given-names>SN</given-names></name><name><surname>Fokin</surname><given-names>A</given-names></name><name><surname>Visweshwaran</surname><given-names>SP</given-names></name><name><surname>Rocques</surname><given-names>N</given-names></name><name><surname>Polesskaya</surname><given-names>A</given-names></name><name><surname>Schnitzler</surname><given-names>A</given-names></name><name><surname>Vacher</surname><given-names>S</given-names></name><name><surname>Denisov</surname><given-names>EV</given-names></name><name><surname>Tashireva</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Cortical branched actin determines cell cycle progression</article-title><source>Cell Res</source><year>2019</year><volume>29</volume><fpage>432</fpage><lpage>445</lpage><pub-id pub-id-type="pmcid">PMC6796858</pub-id><pub-id pub-id-type="pmid">30971746</pub-id><pub-id pub-id-type="doi">10.1038/s41422-019-0160-9</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>RD</given-names></name><name><surname>Heuser</surname><given-names>JA</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>6181</fpage><lpage>6186</lpage><pub-id pub-id-type="pmcid">PMC27619</pub-id><pub-id pub-id-type="pmid">9600938</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.11.6181</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newsome</surname><given-names>TP</given-names></name><name><surname>Scaplehorn</surname><given-names>N</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>SRC mediates a switch from microtubule-to actin-based motility of vaccinia virus</article-title><source>Science</source><year>2004</year><volume>306</volume><fpage>124</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">15297625</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newsome</surname><given-names>TP</given-names></name><name><surname>Weisswange</surname><given-names>I</given-names></name><name><surname>Frischknecht</surname><given-names>F</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus</article-title><source>Cell Microbiol</source><year>2006</year><volume>8</volume><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">16441434</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolen</surname><given-names>BJ</given-names></name><name><surname>Tomasevic</surname><given-names>N</given-names></name><name><surname>Russell</surname><given-names>A</given-names></name><name><surname>Pierce</surname><given-names>DW</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>McCormick</surname><given-names>CD</given-names></name><name><surname>Hartman</surname><given-names>J</given-names></name><name><surname>Sakowicz</surname><given-names>R</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>Characterization of two classes of small molecule inhibitors of Arp2/3 complex</article-title><source>Nature</source><year>2009</year><volume>460</volume><fpage>1031</fpage><lpage>1034</lpage><pub-id pub-id-type="pmcid">PMC2780427</pub-id><pub-id pub-id-type="pmid">19648907</pub-id><pub-id pub-id-type="doi">10.1038/nature08231</pub-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes-Santos</surname><given-names>CJ</given-names></name><name><surname>Kuehn</surname><given-names>H</given-names></name><name><surname>Boast</surname><given-names>B</given-names></name><name><surname>Hwang</surname><given-names>S</given-names></name><name><surname>Kuhns</surname><given-names>DB</given-names></name><name><surname>Stoddard</surname><given-names>J</given-names></name><name><surname>Niemela</surname><given-names>JE</given-names></name><name><surname>Fink</surname><given-names>DL</given-names></name><name><surname>Pittaluga</surname><given-names>S</given-names></name><name><surname>Abu-Asab</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><elocation-id>3708</elocation-id><pub-id pub-id-type="pmcid">PMC10287756</pub-id><pub-id pub-id-type="pmid">37349293</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-39272-0</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papalazarou</surname><given-names>V</given-names></name><name><surname>Machesky</surname><given-names>LM</given-names></name></person-group><article-title>The cell pushes back: The Arp2/3 complex is a key orchestrator of cellular responses to environmental forces</article-title><source>Curr Opin Cell Biol</source><year>2021</year><volume>68</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="pmcid">PMC7938217</pub-id><pub-id pub-id-type="pmid">32977244</pub-id><pub-id pub-id-type="doi">10.1016/j.ceb.2020.08.012</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randzavola</surname><given-names>LO</given-names></name><name><surname>Strege</surname><given-names>K</given-names></name><name><surname>Juzans</surname><given-names>M</given-names></name><name><surname>Asano</surname><given-names>Y</given-names></name><name><surname>Stinchcombe</surname><given-names>JC</given-names></name><name><surname>Gawden-Bone</surname><given-names>CM</given-names></name><name><surname>Seaman</surname><given-names>MN</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Griffiths</surname><given-names>GM</given-names></name></person-group><article-title>Loss of ARPC1B impairs cytotoxic T lymphocyte maintenance and cytolytic activity</article-title><source>J Clin Invest</source><year>2019</year><volume>129</volume><fpage>5600</fpage><lpage>5614</lpage><pub-id pub-id-type="pmcid">PMC6877333</pub-id><pub-id pub-id-type="pmid">31710310</pub-id><pub-id pub-id-type="doi">10.1172/JCI129388</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeves</surname><given-names>PM</given-names></name><name><surname>Bommarius</surname><given-names>B</given-names></name><name><surname>Lebeis</surname><given-names>S</given-names></name><name><surname>McNulty</surname><given-names>S</given-names></name><name><surname>Christensen</surname><given-names>J</given-names></name><name><surname>Swimm</surname><given-names>A</given-names></name><name><surname>Chahroudi</surname><given-names>A</given-names></name><name><surname>Chavan</surname><given-names>R</given-names></name><name><surname>Feinberg</surname><given-names>MB</given-names></name><name><surname>Veach</surname><given-names>D</given-names></name><etal/></person-group><article-title>Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases</article-title><source>Nat Med</source><year>2005</year><volume>11</volume><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">15980865</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietdorf</surname><given-names>J</given-names></name><name><surname>Ploubidou</surname><given-names>A</given-names></name><name><surname>Reckmann</surname><given-names>I</given-names></name><name><surname>Holmstrom</surname><given-names>A</given-names></name><name><surname>Frischknecht</surname><given-names>F</given-names></name><name><surname>Zettl</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>T</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus</article-title><source>Nat Cell Biol</source><year>2001</year><volume>3</volume><fpage>992</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">11715020</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risca</surname><given-names>VI</given-names></name><name><surname>Wang</surname><given-names>EB</given-names></name><name><surname>Chaudhuri</surname><given-names>O</given-names></name><name><surname>Chia</surname><given-names>JJ</given-names></name><name><surname>Geissler</surname><given-names>PL</given-names></name><name><surname>Fletcher</surname><given-names>DA</given-names></name></person-group><article-title>Actin filament curvature biases branching direction</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>2913</fpage><lpage>2918</lpage><pub-id pub-id-type="pmcid">PMC3286980</pub-id><pub-id pub-id-type="pmid">22308368</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1114292109</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname><given-names>W</given-names></name><name><surname>Martins</surname><given-names>JP</given-names></name><name><surname>Carvalho</surname><given-names>FA</given-names></name><name><surname>Voituriez</surname><given-names>R</given-names></name><name><surname>Abella</surname><given-names>JVG</given-names></name><name><surname>Santos</surname><given-names>NC</given-names></name><name><surname>Cadot</surname><given-names>B</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><name><surname>Gomes</surname><given-names>ER</given-names></name></person-group><article-title>Myofibril contraction and crosslinking drive nuclear movement to the periphery of skeletal muscle</article-title><source>Nat Cell Biol</source><year>2017</year><volume>19</volume><fpage>1189</fpage><lpage>1201</lpage><pub-id pub-id-type="pmcid">PMC5675053</pub-id><pub-id pub-id-type="pmid">28892082</pub-id><pub-id pub-id-type="doi">10.1038/ncb3605</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romet-Lemonne</surname><given-names>G</given-names></name><name><surname>Guichard</surname><given-names>B</given-names></name><name><surname>Jegou</surname><given-names>A</given-names></name></person-group><article-title>Using Microfluidics Single Filament Assay to Study Formin Control of Actin Assembly</article-title><source>Methods Mol Biol</source><year>2018</year><volume>1805</volume><fpage>75</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">29971713</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotty</surname><given-names>JD</given-names></name><name><surname>Brighton</surname><given-names>HE</given-names></name><name><surname>Craig</surname><given-names>SL</given-names></name><name><surname>Asokan</surname><given-names>SB</given-names></name><name><surname>Cheng</surname><given-names>N</given-names></name><name><surname>Ting</surname><given-names>JP</given-names></name><name><surname>Bear</surname><given-names>JE</given-names></name></person-group><article-title>Arp2/3 Complex Is Required for Macrophage Integrin Functions but Is Dispensable for FcR Phagocytosis and In Vivo Motility</article-title><source>Dev Cell</source><year>2017</year><volume>42</volume><fpage>498</fpage><lpage>513</lpage><elocation-id>e496</elocation-id><pub-id pub-id-type="pmcid">PMC5601320</pub-id><pub-id pub-id-type="pmid">28867487</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2017.08.003</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotty</surname><given-names>JD</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Bear</surname><given-names>JE</given-names></name></person-group><article-title>New insights into the regulation and cellular functions of the ARP2/3 complex</article-title><source>Nat Rev Mol Cell Biol</source><year>2013</year><volume>14</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">23212475</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouiller</surname><given-names>I</given-names></name><name><surname>Xu</surname><given-names>XP</given-names></name><name><surname>Amann</surname><given-names>KJ</given-names></name><name><surname>Egile</surname><given-names>C</given-names></name><name><surname>Nickell</surname><given-names>S</given-names></name><name><surname>Nicastro</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name><name><surname>Volkmann</surname><given-names>N</given-names></name><name><surname>Hanein</surname><given-names>D</given-names></name></person-group><article-title>The structural basis of actin filament branching by the Arp2/3 complex</article-title><source>J Cell Biol</source><year>2008</year><volume>180</volume><fpage>887</fpage><lpage>895</lpage><pub-id pub-id-type="pmcid">PMC2265399</pub-id><pub-id pub-id-type="pmid">18316411</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200709092</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadhu</surname><given-names>L</given-names></name><name><surname>Tsopoulidis</surname><given-names>N</given-names></name><name><surname>Hasanuzzaman</surname><given-names>M</given-names></name><name><surname>Laketa</surname><given-names>V</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><name><surname>Fackler</surname><given-names>OT</given-names></name></person-group><article-title>ARPC5 isoforms and their regulation by calcium-calmodulin-N-WASP drive distinct Arp2/3-dependent actin remodeling events in CD4 T cells</article-title><source>Elife</source><year>2023</year><volume>12</volume><elocation-id>e82450</elocation-id><pub-id pub-id-type="pmcid">PMC10171864</pub-id><pub-id pub-id-type="pmid">37162507</pub-id><pub-id pub-id-type="doi">10.7554/eLife.82450</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaplehorn</surname><given-names>N</given-names></name><name><surname>Holmstrom</surname><given-names>A</given-names></name><name><surname>Moreau</surname><given-names>V</given-names></name><name><surname>Frischknecht</surname><given-names>F</given-names></name><name><surname>Reckmann</surname><given-names>I</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">12007418</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><etal/></person-group><article-title>Fiji: an open-source plattorm for biological-image analysis</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="pmcid">PMC3855844</pub-id><pub-id pub-id-type="pmid">22743772</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmelz</surname><given-names>M</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Ericsson</surname><given-names>M</given-names></name><name><surname>Wolffe</surname><given-names>EJ</given-names></name><name><surname>Shida</surname><given-names>H</given-names></name><name><surname>Hiller</surname><given-names>G</given-names></name><name><surname>Griffiths</surname><given-names>G</given-names></name></person-group><article-title>Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network</article-title><source>J Virol</source><year>1994</year><volume>68</volume><fpage>130</fpage><lpage>147</lpage><pub-id pub-id-type="pmcid">PMC236272</pub-id><pub-id pub-id-type="pmid">8254722</pub-id><pub-id pub-id-type="doi">10.1128/jvi.68.1.130-147.1994</pub-id></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrank</surname><given-names>BR</given-names></name><name><surname>Aparicio</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Chait</surname><given-names>BT</given-names></name><name><surname>Gundersen</surname><given-names>GG</given-names></name><name><surname>Gottesman</surname><given-names>ME</given-names></name><name><surname>Gautier</surname><given-names>J</given-names></name></person-group><article-title>Nuclear ARP2/3 drives DNA break clustering for homology-directed repair</article-title><source>Nature</source><year>2018</year><volume>559</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="pmcid">PMC6145447</pub-id><pub-id pub-id-type="pmid">29925947</pub-id><pub-id pub-id-type="doi">10.1038/s41586-018-0237-5</pub-id></element-citation></ref><ref id="R63"><element-citation publication-type="other"><collab>Schrodinger, LLC</collab><source>The PyMOL Molecular Graphics System, Version 1.3r1</source><year>2010</year></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sindram</surname><given-names>E</given-names></name><name><surname>Caballero-Oteyza</surname><given-names>A</given-names></name><name><surname>Kogata</surname><given-names>N</given-names></name><name><surname>Chor Mei Huang</surname><given-names>S</given-names></name><name><surname>Alizadeh</surname><given-names>Z</given-names></name><name><surname>Gamez-Diaz</surname><given-names>L</given-names></name><name><surname>Fazlollhi</surname><given-names>MR</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Grimbacher</surname><given-names>B</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><etal/></person-group><article-title>ARPC5 deficiency leads to severe early-onset systemic inflammation and mortality</article-title><source>Dis Model Mech</source><year>2023</year><volume>16</volume><elocation-id>dmm050145</elocation-id><pub-id pub-id-type="pmcid">PMC10387347</pub-id><pub-id pub-id-type="pmid">37382373</pub-id><pub-id pub-id-type="doi">10.1242/dmm.050145</pub-id></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>BA</given-names></name><name><surname>Padrick</surname><given-names>SB</given-names></name><name><surname>Doolittle</surname><given-names>LK</given-names></name><name><surname>Daugherty-Clarke</surname><given-names>K</given-names></name><name><surname>Correa</surname><given-names>IR</given-names><suffix>Jr</suffix></name><name><surname>Xu</surname><given-names>MQ</given-names></name><name><surname>Goode</surname><given-names>BL</given-names></name><name><surname>Rosen</surname><given-names>MK</given-names></name><name><surname>Gelles</surname><given-names>J</given-names></name></person-group><article-title>Three-color single molecule imaging shows WASP detachment from Arp2/3 complex triggers actin filament branch formation</article-title><source>Elife</source><year>2013</year><volume>2</volume><elocation-id>e01008</elocation-id><pub-id pub-id-type="pmcid">PMC3762362</pub-id><pub-id pub-id-type="pmid">24015360</pub-id><pub-id pub-id-type="doi">10.7554/eLife.01008</pub-id></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somech</surname><given-names>R</given-names></name><name><surname>Lev</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>YN</given-names></name><name><surname>Simon</surname><given-names>AJ</given-names></name><name><surname>Barel</surname><given-names>O</given-names></name><name><surname>Schiby</surname><given-names>G</given-names></name><name><surname>Avivi</surname><given-names>C</given-names></name><name><surname>Barshack</surname><given-names>I</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in ARPC1B</article-title><source>J Immunol</source><year>2017</year><volume>199</volume><fpage>4036</fpage><lpage>4045</lpage><pub-id pub-id-type="pmcid">PMC5726601</pub-id><pub-id pub-id-type="pmid">29127144</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1700460</pub-id></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spudich</surname><given-names>JA</given-names></name><name><surname>Watt</surname><given-names>S</given-names></name></person-group><article-title>The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin</article-title><source>J Biol Chem</source><year>1971</year><volume>246</volume><fpage>4866</fpage><lpage>4871</lpage><pub-id pub-id-type="pmid">4254541</pub-id></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volpi</surname><given-names>S</given-names></name><name><surname>Cicalese</surname><given-names>MP</given-names></name><name><surname>Tuijnenburg</surname><given-names>P</given-names></name><name><surname>Tool</surname><given-names>ATJ</given-names></name><name><surname>Cuadrado</surname><given-names>E</given-names></name><name><surname>Abu-Halaweh</surname><given-names>M</given-names></name><name><surname>Ahanchian</surname><given-names>H</given-names></name><name><surname>Alzyoud</surname><given-names>R</given-names></name><name><surname>Akdemir</surname><given-names>ZC</given-names></name><name><surname>Barzaghi</surname><given-names>F</given-names></name><etal/></person-group><article-title>A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency</article-title><source>J Allergy Clin Immunol</source><year>2019</year><volume>143</volume><fpage>2296</fpage><lpage>2299</lpage><pub-id pub-id-type="pmcid">PMC6677392</pub-id><pub-id pub-id-type="pmid">30771411</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2019.02.003</pub-id></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Loeffelholz</surname><given-names>O</given-names></name><name><surname>Purkiss</surname><given-names>A</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Kjaer</surname><given-names>S</given-names></name><name><surname>Kogata</surname><given-names>N</given-names></name><name><surname>Romet-Lemonne</surname><given-names>G</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><name><surname>Moores</surname><given-names>CA</given-names></name></person-group><article-title>Cryo-EM of human Arp2/3 complexes provides structural insights into actin nucleation modulation by ARPC5 isoforms</article-title><source>Biol Open</source><year>2020</year><volume>9</volume><elocation-id>bio054304</elocation-id><pub-id pub-id-type="pmcid">PMC7406314</pub-id><pub-id pub-id-type="pmid">32661131</pub-id><pub-id pub-id-type="doi">10.1242/bio.054304</pub-id></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>AR</given-names></name><name><surname>Luan</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>SL</given-names></name><name><surname>Nolen</surname><given-names>BJ</given-names></name></person-group><article-title>Dip1 defines a class of Arp2/3 complex activators that function without preformed actin filaments</article-title><source>Curr Biol</source><year>2013</year><volume>23</volume><fpage>1990</fpage><lpage>1998</lpage><pub-id pub-id-type="pmcid">PMC3930447</pub-id><pub-id pub-id-type="pmid">24120641</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2013.08.029</pub-id></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisswange</surname><given-names>I</given-names></name><name><surname>Newsome</surname><given-names>TP</given-names></name><name><surname>Schleich</surname><given-names>S</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><article-title>The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19262673</pub-id></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>MD</given-names></name><name><surname>DePace</surname><given-names>AH</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Iwamatsu</surname><given-names>A</given-names></name><name><surname>Mitchison</surname><given-names>TJ</given-names></name></person-group><article-title>The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly</article-title><source>J Cell Biol</source><year>1997</year><volume>138</volume><fpage>375</fpage><lpage>384</lpage><pub-id pub-id-type="pmcid">PMC2138188</pub-id><pub-id pub-id-type="pmid">9230079</pub-id><pub-id pub-id-type="doi">10.1083/jcb.138.2.375</pub-id></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Asokan</surname><given-names>SB</given-names></name><name><surname>Berginski</surname><given-names>ME</given-names></name><name><surname>Haynes</surname><given-names>EM</given-names></name><name><surname>Sharpless</surname><given-names>NE</given-names></name><name><surname>Griffith</surname><given-names>JD</given-names></name><name><surname>Gomez</surname><given-names>SM</given-names></name><name><surname>Bear</surname><given-names>JE</given-names></name></person-group><article-title>Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis</article-title><source>Cell</source><year>2012</year><volume>148</volume><fpage>973</fpage><lpage>987</lpage><pub-id pub-id-type="pmcid">PMC3707508</pub-id><pub-id pub-id-type="pmid">22385962</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2011.12.034</pub-id></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Orozco</surname><given-names>C</given-names></name><name><surname>Boyer</surname><given-names>J</given-names></name><name><surname>Leglise</surname><given-names>M</given-names></name><name><surname>Goodale</surname><given-names>J</given-names></name><name><surname>Batalov</surname><given-names>S</given-names></name><name><surname>Hodge</surname><given-names>CL</given-names></name><name><surname>Haase</surname><given-names>J</given-names></name><name><surname>Janes</surname><given-names>J</given-names></name><name><surname>Huss</surname><given-names>JW</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources</article-title><source>Genome Biol</source><year>2009</year><volume>10</volume><elocation-id>R130</elocation-id><pub-id pub-id-type="pmcid">PMC3091323</pub-id><pub-id pub-id-type="pmid">19919682</pub-id><pub-id pub-id-type="doi">10.1186/gb-2009-10-11-r130</pub-id></element-citation></ref><ref id="R75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>Y</given-names></name><name><surname>Oya</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>A</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name></person-group><article-title>Use of CK-548 and CK-869 as Arp2/3 complex inhibitors directly suppresses microtubule assembly both in vitro and in vivo</article-title><source>Biochem Biophys Res Commun</source><year>2018</year><volume>496</volume><fpage>834</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">29395083</pub-id></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>XF</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name><name><surname>Forscher</surname><given-names>P</given-names></name></person-group><article-title>Arp2/3 complex-dependent actin networks constrain myosin II function in driving retrograde actin flow</article-title><source>J Cell Biol</source><year>2012</year><volume>197</volume><fpage>939</fpage><lpage>956</lpage><pub-id pub-id-type="pmcid">PMC3384413</pub-id><pub-id pub-id-type="pmid">22711700</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201111052</pub-id></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Han</surname><given-names>YM</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Chi</surname><given-names>SW</given-names></name><name><surname>Moon</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Benproperine, an ARPC2 inhibitor, suppresses cancer cell migration and tumor metastasis</article-title><source>Biochem Pharmacol</source><year>2019</year><volume>163</volume><fpage>46</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">30710516</pub-id></element-citation></ref><ref id="R78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmet</surname><given-names>A</given-names></name><name><surname>Van Eeuwen</surname><given-names>T</given-names></name><name><surname>Boczkowska</surname><given-names>M</given-names></name><name><surname>Rebowski</surname><given-names>G</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Dominguez</surname><given-names>R</given-names></name></person-group><article-title>Cryo-EM structure of NPF-bound human Arp2/3 complex and activation mechanism</article-title><source>Sci Adv</source><year>2020</year><volume>6</volume><elocation-id>eaaz7651</elocation-id><pub-id pub-id-type="pmcid">PMC7274804</pub-id><pub-id pub-id-type="pmid">32917641</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.aaz7651</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>CK-869, but not CK-666 fully inhibits vaccinia-induced actin polymerisation.</title><p><bold>A.</bold> Representative immunofluorescence image of a HeLa cell infected with vaccinia virus at 9 hours post-infection and labelled with an antibody against cortactin and stained with phalloidin to visualize F-actin. Extra-cellular virus attached to plasma membrane are labelled with an antibody against the viral protein B5. Scale bar = 10 μm. <bold>B.</bold> Representative images showing localization of cortactin in HeLa cells infected with vaccinia at 9 hours post-infection after 1 hour treatment with CK-666 or CK-869 at the specified concentrations. Scale bar = 10 μm. The inset colour images show 2x magnifications of the yellow boxed regions with cortactin (green) and extra-cellular virus (magenta). <bold>C.</bold> The graph shows quantification of the mean number of extracellular virus co-localising with cortactin from three independent repeats with the error bar representing standard deviation. 10 cells and 150 virus particles were analysed in each experiment. A two-tailed unpaired t-test was used to analyse the statistical significance between different drugs at the same concentration as well as between the drug and DMSO control. ns = not significant. * = p-value &lt; 0.05. ** = p-value &lt; 0.01. *** = p-value &lt; 0.001. **** = p-value &lt; 0.0001.</p></caption><graphic xlink:href="EMS191787-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>CK-666 does not inhibit ArpC1B containing Arp2/3 complexes.</title><p><bold>A</bold>. Representative plots showing the polymerization of pyrene labelled actin (Fluorescence Intensity) when Arp2/3 iso-complexes containing ArpC1A/C5L (left) or ArpC1B/C5L (right) are activated by GST-N-WASP-VCA in the absence (blue) or presence of 100 μM CK-666 (yellow) or CK-869 (green). <bold>B.</bold> Representative TIRF images showing mother filaments (magenta) and new daughter branches (cyan) 2 minutes after Arp2/3 iso-complexes containing ArpC1A/C5, ArpC1A/C5L, ArpC1B/C5 or ArpC1B/C5L were activated by GST-N-WASP-VCA in the absence (DMSO) or presence of 100 μM CK-666 or CK-869. Scale bar = 5 μm. The graph shows the quantification of the mean branching rate for each condition from three independent experiments with the error bar representing standard deviation. Two tailed paired t-test has been applied to analyse the statistical significance. * = p-value &lt; 0.05. *** = p-value &lt; 0.001. ns = not significant. <bold>C.</bold> The branching rate of Arp2/3 complex containing ArpC1A/C5L and ArpC1B/C5L were measured at the indicated concentrations of CK-666 (top) and CK-869 (bottom). The data was fitted with equation Y=Bottom + (Top-Bottom)/(1+(X/IC<sub>50</sub>)) to calculate the half-maximal inhibitory concentration of the drugs (IC<sub>50</sub>), which is indicated (ND = not determined). The points and error bars represent the mean and the standard deviation from at least two independent measurements.</p></caption><graphic xlink:href="EMS191787-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>CK666 has no adverse impact on murine bone marrow-derived macrophages</title><p><bold>A.</bold> Treatment of murine bone marrow-derived macrophages (BMDM) with 100 μM CK-869 but not DMSO or CK-666 induces cell rounding. The graphs show the mean ratio of length and width as well as cell thickness from five independent experiments with error bars representing the standard deviation. In each experimental condition, at least 30 cells were randomly chosen and analysed. Two tailed unpaired t-test was used to analyse the statistical significance. <bold>B.</bold> Representative phase images of BMDM treated with DMSO, CK-666 or CK-869 over 20 minutes. Scale bar = 20 μm. <bold>C.</bold> Quantification of the mean migration speed of BMDM treated with DMSO, CK-666 or CK-869 from five independent experiments with error bars representing the standard deviation. In each experimental condition, at least 30 cells were randomly chosen and analysed. Two tailed unpaired t-test was used to analyse the statistical significance. <bold>D</bold>. The graph shows the quantification of the phagocytosis efficiency of zymosan by murine bone marrow-derived macrophages treated with DMSO, CK-666 or CK-869 over 120 minutes. In each experimental condition, 10<sup>4</sup> cells were analysed using flow cytometry. Each point represents the mean of three independent technical repeats and error bars represent the standard deviation. Two-way ANOVA test has been applied to analyse the statistical significance. ** = p-value &lt; 0.01. *** = p-value &lt; 0.001. **** means p-value &lt; 0.0001. ns = not significant.</p></caption><graphic xlink:href="EMS191787-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Analysis of Arp2/3 complex binding to actin filaments or VCA.</title><p><bold>A.</bold> Left panel shows representative Coomassie stained protein gels of the co-sedimentation of Arp2/3 complexes containing ArpC5L together with ArpC1A (top) or ArpC1B (bottom) with 15 μM actin (P = pellet) in the absence (DMSO) or presence of 100 μM CK-666 or CK-869. The supernatant (S) contains unbound Arp2/3 complexes and non-pelleted G-actin. MK represents the molecular weight markers. Right graph shows the quantification of the mean co-sedimentation fraction of the indicated Arp2/3 complexes in the absence (DMSO) or presence of CK-666 or CK-869 from three independent experiments at 3 and 15 μM actin, with the error bars indicating the standard deviation. Two tailed paired t-test was used to analyse the statistical significance. * = p-value &lt; 0.05. ns = not significant. <bold>B.</bold> Immunoblots (left panels) using an ArpC2 antibody demonstrate that 100 μM CK-666 or CK-869 does not impact the interaction of Arp2/3 complexes ArpC5L together with ArpC1A (top) or ArpC1B (bottom) with GST-N-WASP-VCA (Ponceau - red). Right graph shows the quantification of the mean pull down fraction of the indicated Arp2/3 complexes in the absence (DMSO) or presence of CK-666 or CK-869 from three independent experiments, with the error bars indicating the standard deviation. Two tailed paired t-test was used to analyse the statistical significance. ns = not significant.</p></caption><graphic xlink:href="EMS191787-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>The impact of CK-666 and CK-869 on SPIN90 activation of Arp2/3 complexes</title><p><bold>A</bold>. The maximum rate of pyrene actin polymerisation stimulated by SPIN90-Arp2/3 iso-complexes containing ArpC1A/C5L and ArpC1B/C5L in the presence of the indicated concentrations of CK-666 (top) and CK-869 (bottom). The data was fitted with equation Y=Bottom + (Top-Bottom)/(1+(X/IC<sub>50</sub>)) to calculate the half-maximal inhibitory concentration of the drugs (IC<sub>50</sub>), which is indicated. The points and error bars represent the mean and the standard deviation of at least two independent measurements. <bold>B.</bold> Representative TIRF images of actin filament assembly induced by Arp2/3 complexes containing ArpC1A/C5L or ArpC1B/C5L after activation by SPIN90-Cter in the absence (DMSO) or presence of 100 μM CK-666 or CK-869 at the indicated times. Scale bar = 10 μm. The graph shows the quantification of the mean filament density at 240 s from three independent experiments with the error bar representing standard deviation. Two tailed unpaired t-test was used to analyse the statistical significance and *** = p-value &lt; 0.001. <bold>C.</bold> The left panels show immunoblots of GST-SPIN90-Cter (Ponceau - red) pulldown assays of the indicated Arp2/3 iso-complexes (detected by ArpC2 antibody) in the absence (DMSO) or presence of 100 μM CK-666 or CK-869. The right panel shows the quantification of the mean bound Arp2/3 complex normalized to the DMSO control for three independent pulldown assays with the error bar representing standard deviation. Two tailed paired t-test was used to analyse the statistical significance. ns = not significant. * = p-value &lt; 0.5.</p></caption><graphic xlink:href="EMS191787-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Impacts of drugs on Arp3B containing complexes</title><p><bold>A</bold> Representative TIRF images showing mother filaments (magenta) and newly polymerised daughter actin branches (cyan) 2 minutes after Arp2/3 complex containing Arp3B/ArpC1B/C5L was activated by GST-N-WASP-VCA in the absence (DMSO) or presence of 100 μM CK-666 or CK-869. Scale bar = 5 μm. The graph shows the quantification of the mean branching rate for each condition from three independent experiments with the error bar representing standard deviation. Two tailed paired t-test was used to analyse the statistical significance and ns = not significant. <bold>B.</bold> Representative TIRF images of actin filament assembly induced by Arp2/3 complex containing Arp3B/ArpC1B/C5L after activation by SPIN90-Cter in the absence (DMSO) or presence of 100 μM CK-666 or CK-869 at the indicated times. Scale bar = 10 μm. The graph shows the quantification of the mean filament density at 240 s from three independent experiments with the error bar representing standard deviation. Two tailed unpaired t-test was used to analyse the statistical significance. ns = not significant. *** presents p-value &lt; 0.001. <bold>C</bold>. The maximum rate of pyrene actin polymerisation stimulated by Arp2/3 complex containing Arp3B/ArpC1B/C5L activated by either GST-N-WASP-VCA or SPIN90 Cter at the indicated CK-869 concentration. The points and error bars represent the mean and the standard deviation of at least two independent measurements. <bold>D</bold>. The top image shows that in the Arp2/3 complex (PDB: 3ULE), CK-869 has hydrophobic interactions with Leu 112 and Thr 126 of Arp3. The bottom image shows that in Arp3B, Leu 112 and Thr 126 are replaced by Met 112 and Leu 126, the latter of which is predicted to have clashes with CK-869.</p></caption><graphic xlink:href="EMS191787-f006"/></fig></floats-group></article>